Loading the company…
Loading the company…
In the last ten years FDA made 44 decisions for Med-El (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2019 (11). The latest was on 2026-10-09.
| Family | Decisions on record |
|---|---|
| Cochlear implants | 129 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-10-09 | PMA | P000025-S136 | MED-EL Cochlear Implant System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-01-23 | PMA | P000025-S137 | MED-EL Cochlear Implant · Postapproval Study Protocol |
| 2025-11-26 | PMA | P000025-S134 | MED-EL CI System · Labeling Change - Indications/instructions/shelf life/tradename |
| 2025-04-24 | PMA | P000025-S135 | COMBI 40+ COCHLEAR IMPLANT SYSTEM · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
In 2025, Med-El reported engagement with 241 surgeons and other clinicians in the states MedaRep covers, worth $346K in consulting, speaking, meals and travel for its device products, the most in North Carolina ($79K to 12). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: North Carolina ($79K, 12 engaged), Pennsylvania ($37K, 8 engaged), California ($25K, 16 engaged), Idaho ($24K, 3 engaged), Florida ($14K, 28 engaged).
| 2025-02-13 | PMA | P000025-S131 | SONNET 3 (EAS) Audio Processor, MAESTRO 11 · Change Design/Components/Specifications/Material |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Med-El.